Welcome to our dedicated page for Chimera Invt SEC filings (Ticker: CIM), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Chimera Investment Corporation (NYSE: CIM) SEC filings page on Stock Titan brings together the company’s regulatory disclosures from the U.S. Securities and Exchange Commission, including Forms 8-K, 10-K, 10-Q, registration statements, and related exhibits. Chimera is a mortgage-focused real estate investment trust that invests in residential mortgage loans, Non-Agency RMBS, Agency RMBS, Agency CMBS, mortgage servicing rights (MSRs), business purpose and investor loans, and other real estate-related assets, and its filings provide detailed insight into these activities.
Recent Form 8-K filings cover a range of material events: quarterly earnings releases, common and preferred stock dividend declarations, public offerings of senior notes, and the completion of the acquisition of HomeXpress Mortgage Corp. These current reports often include or reference press releases, investor presentations, underwriting agreements, indentures, inducement award plans, and pro forma financial information.
Chimera’s periodic reports, such as its Annual Report on Form 10-K and Quarterly Reports on Form 10-Q, which are referenced in its 8-K risk factor supplements, discuss its mortgage asset portfolio, leverage, consolidated variable interest entities (VIEs), investment management and advisory services, and extensive risk factors related to funding, credit, interest rates, regulation, and REIT status. These filings also address the company’s use of non-GAAP measures like earnings available for distribution.
On this page, Stock Titan enhances Chimera’s filings with AI-powered summaries that explain key sections of lengthy documents, highlight important changes, and surface items such as new debt issuances, acquisition terms, and updates to risk factors. Users can quickly scan new 8-Ks for dividend actions or capital markets transactions, and review 10-Q and 10-K discussions of mortgage assets, securitizations, and leverage.
In addition, this page tracks registered securities and senior notes listed in Chimera’s filings, including its common stock, multiple series of cumulative redeemable preferred stock, and senior notes due 2029 and 2030. Investors can use the filings archive and AI summaries to monitor Chimera’s capital structure, financing activities, and ongoing compliance disclosures in one place.
Chimera Investment Corp’s Chief Investment Officer Jack Lee Macdowell Jr reported an award of 85,701 shares of common stock on January 20, 2026. These shares represent restricted stock units (RSUs), with each RSU economically equivalent to one share of Chimera common stock and scheduled to vest in three equal installments on December 31 of 2026, 2027, and 2028, and to be settled entirely in shares.
Following this grant, Macdowell beneficially owns 312,791 shares of Chimera common stock, which includes dividend equivalent rights issued on RSUs. The transaction price is reported as $0 per share, reflecting that this is an equity compensation award rather than an open-market purchase.
Chimera Investment Corporation’s Chief Financial Officer, Viswanathan Subramaniam, reported an equity award tied to the company’s common stock. On January 20, 2026 he was granted 54,537 restricted stock units (RSUs), each economically equivalent to one share of Chimera common stock and reported at a transaction price of $0, reflecting the nature of the award rather than a market purchase.
The RSUs are scheduled to vest in three equal installments on December 31 of 2026, 2027 and 2028, and will be settled entirely in Chimera common shares. Following this grant, the reporting person beneficially owned 247,826 shares of Chimera common stock on a direct basis, a figure that also includes dividend equivalent rights, which are treated as the economic equivalent of additional shares.
Chimera Investment Corp’s Chief Legal Officer and Secretary, Miyun Sung, reported receiving 31,164 shares of common stock on January 20, 2026, at a price of $0 per share. These shares represent common stock underlying restricted stock units that are scheduled to vest in three equal installments on December 31 of 2026, 2027, and 2028 and will be settled entirely in Chimera common stock.
After this grant, Sung beneficially owns 67,958 shares of Chimera common stock in direct form, with this balance including dividend equivalent rights on the RSUs, each of which is the economic equivalent of one share.
Chimera Investment Corporation’s President and CEO, Phillip John Kardis II, reported an equity award of 194,774 shares of common stock on January 20, 2026. These shares represent restricted stock units (RSUs), each economically equal to one share of Chimera common stock, granted at a price of $0 per share as part of compensation.
The RSUs are scheduled to vest in three equal installments on December 31, 2026, 2027 and 2028, and will be settled entirely in Chimera common stock. Following this grant, Kardis beneficially owns 695,495 shares of Chimera common stock directly, which also include dividend equivalent rights tied to prior RSUs and performance stock units.
Chimera Investment Corporation reported an insider equity transaction by President, CEO, and Director Phillip John Kardis II. On 12/18/2025, he acquired 101,772 shares of Chimera common stock at a stated price of $0, reflecting the vesting of performance stock units and associated dividend equivalent rights. Each performance stock unit and each dividend equivalent right is the economic equivalent of one share of Chimera common stock.
Following this vesting event, Kardis beneficially owns 500,721 shares of Chimera common stock in direct form.
Chimera Investment Corporation’s chief financial officer Subramaniam Viswanathan reported a stock-based compensation event. On 12/18/2025, he acquired 47,251 shares of Chimera common stock at a price of $0, reflecting the vesting of performance stock units and related dividend equivalent rights. Following this transaction, he beneficially owned 193,289 shares of common stock in total, held directly.
The filing explains that each performance stock unit and each dividend equivalent right is economically equivalent to one share of Chimera common stock, and dividend equivalent rights on restricted stock units and performance stock units are included in his common stock balance. This is a routine Form 4 disclosure of equity awards rather than an open-market purchase.
Chimera Investment Corporation disclosed that its board has declared a fourth quarter cash dividend of $0.37 per share on its common stock. The company announced this dividend through a press release dated December 18, 2025, which is attached as an exhibit. The update is provided as a Regulation FD disclosure, meaning it is intended to share the same dividend information with all investors at the same time.
Chimera Investment Corp. reported an insider equity transaction by its Chief Legal Officer & Secretary, Miyun Sung. On 12/01/2025, 2,586 shares of Chimera common stock were withheld at a price of $12.79 per share to cover taxes related to the settlement of deferred shares from previously granted performance stock units (PSUs) and restricted stock units (RSUs). These settlements are tied to the liquidation of Chimera’s Stock Award Deferral Program on November 30, 2025, which had been described in the company’s prior annual report. After this tax-withholding transaction, Sung beneficially owned 36,794 shares of Chimera common stock, including dividend equivalent rights that are economically equal to additional shares.
Chimera Investment Corp’s Chief Financial Officer, Subramaniam Viswanathan, reported an automatic share withholding related to equity compensation. On 12/01/2025, 31,675 shares of Chimera common stock were withheld at a price of $12.79 per share to cover taxes due on the settlement of previously granted performance stock units (PSUs) and restricted stock units (RSUs). These units vested in connection with the liquidation of Chimera’s Stock Award Deferral Program on November 30, 2025. Following this tax withholding, the CFO beneficially owns 145,931 shares of Chimera common stock, which include dividend equivalent rights that are each economically equivalent to one share.
Chimera Investment Corp's President and CEO, who is also a director, reported a Form 4 insider transaction dated 12/01/2025. The filing shows that 102,926 shares of common stock were withheld as payment of taxes tied to the settlement of deferred Chimera shares, following the vesting of prior performance stock units (PSUs) and restricted stock units (RSUs) under the company’s Stock Award Deferral Program, which was liquidated on November 30, 2025. After this tax withholding, the reporting person beneficially owns 394,169 shares of Chimera common stock, which include dividend equivalent rights (DERs), with each DER economically equal to one share.
FAQ
What is the current stock price of Chimera Invt (CIM)?
What is the market cap of Chimera Invt (CIM)?
